Hello,



  • This field is for validation purposes and should be left unchanged.
EECO2 Privacy Policy

HVAC ENERGY FOCUSSED ASSESSMENT OF AN ASEPTIC PHARMACEUTICAL MANUFACTURING SITE

Site: | Location: Italy | Sector: Pharmaceutical Manufacturing

project brief

EECO2 were commissioned to deliver an HVAC energy focussed assessment of this aseptic pharmaceutical manufacturing site.

METHODOLOGY

The energy assessment workshop process has 3 distinct phases. Each of these are important elements that ensure that the output and conclusions are robust and importantly, that the site team and stakeholders have confidence in the findings and recommendations.

Phase 1: Data collection and analysis;

Phase 2: On site assessment workshop event;

Phase 3: Final report preparation, review and action planning

In preparation for the onsite energy assessment workshop event, EECO2 analysed the HVAC data provided by the site and built a bespoke energy model for assessing the site energy consumption and possible savings from the utility systems, including HVAC consumption. We applied a quality risk based approach to the evaluation to ensure the appropriate measures were adopted to maintain quality and safety, whilst reducing energy costs.

SOLUTION

The data analysis, supplemented by onsite observations, showed that HVAC (air movement, heating, cooling and dehumidifying) was the largest user in terms of energy consumption at 61% of site energy consumption and cost. The main areas of opportunity identified were:

Fresh Air Pre-treatment and dehumidification control

BMS Optimisation set point and dead band control

HVAC set back (or turn down) during non-operational times

HVAC optimisation - air change rates in areas are higher than needed to maintain air cleanliness/classification

HVAC replacement where appropriate

Results

Energy savings identified (per year):

13,621,000 kWh

(13,621 MWh)

Energy cost savings identified (per year):

€944,000

20% reduction in site energy costs

Emissions reduction (per year):

3,518 tonnes

of CO2 emissions

The energy savings identified have an overall simple payback period of 1.9 years.

"Excellent technical knowledge of energy efficiency opportunities and quality of deliverables."
Engineering Director
Global Pharmaceautical Manufacturer

LIKE WHAT YOU SEE?

We can do this for you too. Speak to us today to find out what we can deliver for your business.

OUR CLIENTS

AbbVie

Aesica

ALKERMES

Allergan

Amgen

AstraZeneca

BAYER

Catalent

Eli Lilly

GlaxoSmithKline

Novartis

Pfizer

Pharmavite

Purogenix

Sanofi